Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified July 2009 by National Cancer Institute (NCI).
Recruitment status was:  Recruiting
Sponsor:
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00871858
First received: March 27, 2009
Last updated: January 7, 2011
Last verified: July 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2009 (Final data collection date for primary outcome measure)